Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany?
Standard
Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany? / du Bois, A; Schmalfeldt, B; Meier, W; Sehouli, J; Pfisterer, J; Arbeitsgemeinschaft Gynaekologische Onkologie [AGO] Kommission OVAR.
In: INT J GYNECOL CANCER, Vol. 16, No. 5, 03.10.2006, p. 1756-60.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany?
AU - du Bois, A
AU - Schmalfeldt, B
AU - Meier, W
AU - Sehouli, J
AU - Pfisterer, J
AU - Arbeitsgemeinschaft Gynaekologische Onkologie [AGO] Kommission OVAR
PY - 2006/10/3
Y1 - 2006/10/3
N2 - The German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) and the two German cooperative study groups (AGO-OVAR and NOGGO) performed a review of the currently available literature on intraperitoneal first-line treatment in advanced ovarian cancer to consider if this new option should be incorporated into the German guidelines for treatment of ovarian cancer.
AB - The German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) and the two German cooperative study groups (AGO-OVAR and NOGGO) performed a review of the currently available literature on intraperitoneal first-line treatment in advanced ovarian cancer to consider if this new option should be incorporated into the German guidelines for treatment of ovarian cancer.
KW - Antineoplastic Agents
KW - Clinical Trials as Topic
KW - Female
KW - Germany
KW - Humans
KW - Infusions, Parenteral
KW - Ovarian Neoplasms
KW - Practice Guidelines as Topic
U2 - 10.1111/j.1525-1438.2006.00712.x
DO - 10.1111/j.1525-1438.2006.00712.x
M3 - SCORING: Journal article
C2 - 17009967
VL - 16
SP - 1756
EP - 1760
JO - INT J GYNECOL CANCER
JF - INT J GYNECOL CANCER
SN - 1048-891X
IS - 5
ER -